Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity
- 1 February 2006
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 14 (3) , 650-658
- https://doi.org/10.1016/j.bmc.2005.08.063
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect onKATPChannel Activation Properties and Tissue Selectivity of the Nature of the Substituent in the 7- and the 3-Position of 4H-1,2,4-Benzothiadiazine 1,1-DioxidesJournal of Medicinal Chemistry, 2005
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosisScience, 2005
- Treatment of HIV-related Tuberculosis in the Era of Effective Antiretroviral TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2001
- The Need for New Drugs against TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosisNature, 2000
- In Vitro Activities of Sitafloxacin (DU-6859a) and Six Other Fluoroquinolones against 8,796 Clinical Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 2000
- Global Action Against Multidrug-Resistant TuberculosisPublished by American Medical Association (AMA) ,2000
- Antituberculosis activity of certain antifungal and antihelmintic drugsTubercle and Lung Disease, 1999
- 7-Chloro-3-methyl-3,4-dihydro-2 H -1,2,4-benzothiadiazine S , S -dioxide: A partial modulator of AMPA receptor desensitization devoid of neurotoxicityProceedings of the National Academy of Sciences, 1997
- Identification of a Novel Oxazolidinone (U-100480) with Potent Antimycobacterial ActivityJournal of Medicinal Chemistry, 1996